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are important determinants ofsuitability for orthetopic heart ransplantation 
(OHT) that are conventionally assessed by serial dght heart catheterizetions. 
The feasibility of obtaining accurate, non-invasive (NI) estimates of these 
parameters has not been evaluated. Methods: Invasive (INV) measurements 
of TPG and PVR were compared with Echo/Doppler NI estimates in 15 OHT 
candidates (age range 29--59 years, 12 males). NI data included: RA pres- 
sure by IVC size and resplrophasic hange, PA systolic pressure = 4[peak 
TR velocity] 2 + RA, PA diastolic pressure = 4[pulmonaly insufficiency end- 
diastolic velocity] 2 + ~,  PA mean pressure = PA diastolic + 1/3 [PA systolic 
- PA diastolic], pulmonary capillary wedge pressure (PCW) = diastolic BP 
- 4[MR velocity at aortic valve opening] ~z, TPG = PA mean - PCW, cardiac 
output = [transaortic velocity-time integral[[aortic annular area',[HR], PVR = 
TPG/cardiac output. 
Results: 
INV range Mean Z~ (INV - NI) ± 95% conlidence r 
TPG(rcmHg) 3-14 -3.45 4.38 0.93 
PVR(Wood U) 0.09-4,36 -0,85 1.52 0.95 
Both TPG and PVR could be NI determined in 11 patients (73%) and were 
never underestimatsd. An algorithm (NI TPG < 13 and PVR < 4) identified 
80% of patients that were hemodynamically suitable for OHT and excluded 
10(P/,~ of patients with INV TPG > 12 or PVR > 3 (p < 0.02). Conclusion: 
Accurate NI determination ofTPG and PVR is feasible and may obviate the 
need for serial right heart catheterizations in many patients awaiting OHT. 
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Simplified Assessment of Pulmonary Hypertension 
in Heart Transplant Candidates 
Randall C. Starling, Garrie J. Haas. The Ohio State University, Columbus, 
Ohio 
Elevated pulmonary vascular esistance [PVR] is associated with poor out- 
come due to right heart failure after cardiac transplant [TX]. Acute administra- 
tion of vasodilaters ere typically utilized to assess PVR. The purpose of this 
investigation was to determine the effectiveness of sublingual nitroglycerin 
[NTG] to evaluate PVR in prospective candidates for TX. Twenty-six patients 
[pte| mean age 55 years with congestive heart failure [CHFI referred for TX 
evaluation with pulmonary artery [PA] systolic pressure [sys] > 50 mm Hg 
received NTG while being hemodynamically monitored, Comparisons were 
made with 23 CHF pts mean age 52 years that received sodium nitreprusside 
[SNP]. Mean SNP dose was 2.g -4- 2.1 mcg/kg/min and mean NTG dose was 
0.55 mg. The mean duration of the studies was 50 rain. for SNP versus 23 
min. for NTG. 
NTG NTG 8NP SNP 
base peak base peak 
PA Sys 67 48 [28] 71 40 [31 ]
PA Mean [PAM] 44 34 [24] 48 34 [29] 
P,'~ Wedge [PAW] 30 22126] 34 22 [32] 
(PAM-PAW) [TPG I 14 12 [14] 14 12 [12| 
PVR WOOD UNITS 2.7 2.2 [12] 3.0 1 5 [46]* 
SVR dynes-see-era -5 1383 1200[12 | 1404 713145|* 
CARDIAC OUTPUT I/rain 5.5 5.7 [5] 5.2 8.1 [35]" 
MAP 88 86 [2~ 84 71 [1(]]' 
HEART RATE 84 84 [01 94 94 [0[ 
*% change NTG vs SNP p < 0.01. [] percent change. 
Similar declines in PA sys, PAM and TPG were observed with both drugs. 
However, SNP resulted in significantly greater changes in cardiac output, 
SVR, MAP and WOODS units. We conclude that NTG provides a rapid 
and effective alternative for assessing the reactivity of CHF pts with PA 
hypertension. NTG has minimal systemic effect in CHF pts. The TPG is 
red,ced but significant reductions in TSVR and MAP are avoided. 
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Keith D. Aardnson, Tze-Ming Chen, J. Sanford Schwartz, Donna 
M. Mancini. Columbia.Presbyterian Medical Center, New York, NY 
Setsctlon of cardiac transplant U'XP) candidates i  based on measurement 
of pmgnoetio vadablas in CHF and secondary exclusion factors. We derived 
an objective preTXP risk-stratitication system from multivariable analyses 
performed on 268 patients referred to the U of Penn (HUP) from 7/86- 
1/93, and validated this on 204 patience, referred to Columbia (CPMC) from 
7/93--9FJ5. Over 80 variables were prospectively collected: history & phys- 
ical, chemistries, cathatedzaUon data, exemise testing with respiratory gas 
analysis, MUGA and ECG. Patients were follow~ to death; UNOS 1 TXP 
(analyzed as death); UNOS 2 TXP (censored) or alive. Kaplan-Maiar 1- and 
2-year survivals were 74 :E 3% and 61 ± 4% (HUP) and 60 4- 4°/= and 39 d: 
6% (CPMC). Cox modeling was performed on the HUP data set to develop 
"noninvasive only" and "unrestricted ~ (i.e., best combination of nonlnvasively 
& invssively determined variables) models, The noninvasive model included 
ischemic etiology, LVEF, HR, mean BP, QRS >_ 120 ms, peak VO2, serum 
sodium; the unrestricted model was the same except PCW was used instead 
of serum sodium. Model discrimination was determined by calculating the 
area under receiver operating characteristic curves for 1-year survival and 
were as follows: 
Model Cross-Validation (HUP) Validation (CPMC) 
Noninvasive model 0.79 :E 0.03 0.76 :E 0.04 
Invasive model 0.814- 0.03 0.73 :t: 0.05 
In conclusion, a model incorporating seven nonlnvasively obtained clinical 
vadabtss was prospectively validated with good discrimination, Addition of 
invasively determined information did not improve model discrimination, Th!s 
model provides a practical method to improve the objective selection of TXP 
candidates. 
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Cardiac transplantation (TX) in patients (pts) with advanced ischemic car- 
diomyopathy (ICM) and heart failure is limited by a high cost, donor availabil- 
ity, and a high mortality of wait listed candidates. Since Positron Emission 
Tomographic (PET) pattern of myocardial parfusion-metabolism " ismatch" 
has been shown to be predictive of the potential for improvement of LV dys- 
function, heart failure symptoms, and survival after CABG; we hypothesized 
that a PET based decision algorithm in TX candidates identifies a subgroup 
of ICM pts who would be referred to CABG as a less costly alternative to 
TX. ACcordingly, 112 lOtS with ICM {LVEF < 35%) and heart failure who 
were referred to UCLA for TX evaluation underwent PET. In 38/112 pts, 2 or 
more areas of mismatch were identified. Of these 38 pts, 30 received CABG 
rather than TX and 8 underwent medical therapy (MRx) because they had 
either poor coronary targets or refused surgery. O1 the 74 I~ts without PET 
mismatch, 33 had TX and 41 received MRx. Oedoperatlve mortalities were 
similar for CABG and TX (10% vs, 6.1%, p = nsi ~}f note, the 5-year actuarial 
survival rates for pts who received CABG and "(X were also similar (71.4% 
vs. 80.1%, p = ns) and were both significantly higher than that of MRx pts 
(42.4%, p < 0.05). Based on the average cost for PET, CABG, and TX (in- 
cluding the initial and follow-up costs) at our institution ($1,900, $50,000, and 
$200,000, respectively), the PETdriven decision algorithm in management of 
our f12 TX candidates incurred $212,800 cost for PET studies but, resulted 
in diverting 30 pts to CABG ($1,900,000 cost) from potential TX ($6,000,000 
saving); a net total sav;ng of $5,887,200 or $.34,707 per TX candidate. Thus, 
a PET based decision algorithm in the management of cardiac transplant 
candidates identities asubgroup of pts who could undergo CABG rather than 
TX, at a substantial cost saving and with similar peri-operetive and five year 
survival results. 
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Due to donor shortages in heart ransplantation, older donor are being used 
more frequently, et the role of pre-existing coronary artery disease (CAD) in 
the development of transplant coronary artery disease (TCAD) has not been 
well established. Previous studies with intracoronary ultrasound {ICUS) h~ve 
been done using <_ 3 sites/patient and may not accurately assess TCAD. 
We identified and followed 17 transplant patients (Group 1) with a baseline 
(6-8 weeks after transplant) mean maximal intimat thickness (MIT) _> 0.3 mm 
using intracorenary ultrasound (ICUS, 2.9 F or 4.3 F, 30 Mhz). Quantitative 
ICUS was done using morphometde analysis (10 random sites/patient) of 
the left anteflor descending artery at baseline and 1 year. This group was 
compared to 31 transplant patients (Group 2) with a baseline MIT < 0.3 ram. 
Computedzed planimetry was done to obtain the f~!lowing measurements: 
